Peer-reviewed evidence for molecular hydrogen therapy
Six in-depth summaries from journals, university labs and field practitioners — covering the conditions where inhaled H₂ has been studied most rigorously, plus the underlying redox mechanism.
Hydrogen therapy for ME/CFS — a 4-case report
Keio University & MiZ Corp. publish in Medical Gas Research: four myalgic encephalomyelitis / chronic fatigue syndrome patients improved after daily inhalation of 6–7% H₂.
Molecular hydrogen for wound healing & tissue regeneration
Artamonov, LeBaron, Pyatakovich & Minenko (2024) review the antioxidant, anti-inflammatory and pro-angiogenic effects of H₂ across the four phases of wound repair.
Hydrogen therapy across kidney disease — review
13,000-word review (Biomedicines, Keio University / MIZ Corp.) covering basic and clinical evidence for H₂ in AKI, CKD, diabetic nephropathy and dialysis.
Hydrogen therapy for chronic & allergic rhinitis
Yu Shaoqing team at Tongji University Hospital consolidate years of basic-to-clinical research on inhaled hydrogen for chronic upper-airway inflammation.
Hydrogen nanobubbles & oxidative stress — mechanism
Liu Shu lab, Beihang University: how H₂ nanobubbles scavenge ROS and up-regulate endogenous antioxidant enzymes (SOD, GSH-Px).
Ten representative patient improvement cases
Real-world testimonials: gastritis, hypertension, diabetes, hyperuricemia, hyperlipidemia, allergic rhinitis and post-surgical inflammation outcomes after daily H₂ protocols.
Bring molecular hydrogen into your wellness routine
The HHO™ product ecosystem delivers research-comparable molecular hydrogen at home — through inhalation and through the bath.